JP2007501809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007501809A5 JP2007501809A5 JP2006522859A JP2006522859A JP2007501809A5 JP 2007501809 A5 JP2007501809 A5 JP 2007501809A5 JP 2006522859 A JP2006522859 A JP 2006522859A JP 2006522859 A JP2006522859 A JP 2006522859A JP 2007501809 A5 JP2007501809 A5 JP 2007501809A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- reacting
- substituted
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 20
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 2
- 101150065749 Churc1 gene Proteins 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 102100038239 Protein Churchill Human genes 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims 2
- 230000003381 solubilizing effect Effects 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- SXINBFXPADXIEY-UHFFFAOYSA-N 5-Nitrofurfural Chemical compound [O-][N+](=O)C1=CC=C(C=O)O1 SXINBFXPADXIEY-UHFFFAOYSA-N 0.000 claims 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 0 Cc(cc12)c(C)cc1nc(*c1ccc([N+]([O-])=O)[o]1)nc2N(*)* Chemical compound Cc(cc12)c(C)cc1nc(*c1ccc([N+]([O-])=O)[o]1)nc2N(*)* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49333603P | 2003-08-08 | 2003-08-08 | |
| PCT/CA2004/001466 WO2005014585A1 (en) | 2003-08-08 | 2004-08-06 | Halogenated quinazolinyl nitrofurans as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007501809A JP2007501809A (ja) | 2007-02-01 |
| JP2007501809A5 true JP2007501809A5 (https=) | 2007-09-20 |
Family
ID=34135234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006522859A Withdrawn JP2007501809A (ja) | 2003-08-08 | 2004-08-06 | 抗菌剤としてのハロゲン化キナゾリニルニトロフラン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7410974B2 (https=) |
| EP (1) | EP1660486A4 (https=) |
| JP (1) | JP2007501809A (https=) |
| CN (1) | CN1832941A (https=) |
| AU (1) | AU2004262533A1 (https=) |
| BR (1) | BRPI0413372A (https=) |
| CA (1) | CA2534405A1 (https=) |
| MX (1) | MXPA06001552A (https=) |
| WO (1) | WO2005014585A1 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010016646A1 (en) * | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| EP1660486A4 (en) | 2003-08-08 | 2006-12-13 | Ulysses Pharmaceutical Product | HALOGENATED CHINAZOLINYL NITROFURANES AS ANTIBACTERIAL AGENTS |
| US20080146562A1 (en) * | 2003-08-08 | 2008-06-19 | Ulysses Pharmaceutical Products Inc., | Halogenated quinazolinyl nitrofurans as antibacterial agents |
| CN101027299A (zh) * | 2004-09-23 | 2007-08-29 | 尤利塞斯药品公司 | 碳－和杂－环硝基呋喃抗生素及其应用 |
| EP1996732A4 (en) * | 2006-03-02 | 2010-03-31 | Uab Research Foundation | RECOGNITION AND TREATMENT AND DISCOVERY OF REMEDIES AGAINST MYCOBACTERIAL DISEASES |
| JP2010501572A (ja) * | 2006-08-22 | 2010-01-21 | コンサート ファーマシューティカルズ インコーポレイテッド | ４−アミノキナゾリン誘導体およびその使用方法 |
| US20110053964A1 (en) * | 2006-08-22 | 2011-03-03 | Roger Tung | 4-aminoquinazoline derivatives and methods of use thereof |
| WO2008113161A1 (en) * | 2007-03-19 | 2008-09-25 | Ulysses Pharmaceutical Products Inc. | Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same |
| ES2703253T3 (es) | 2010-03-30 | 2019-03-07 | Helperby Therapeutics Ltd | Nueva combinación y uso |
| GB201013207D0 (en) | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
| WO2012017215A1 (en) | 2010-08-05 | 2012-02-09 | Helperby Therapeutics Limited | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| GB201305277D0 (en) | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
| GB201307989D0 (en) | 2013-05-02 | 2013-06-12 | Helperby Therapeutics Ltd | Novel combinations and use |
| GB201401617D0 (en) | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
| CN107530397A (zh) | 2014-12-18 | 2018-01-02 | 赫尔普百治疗有限公司 | 新型组合和用途 |
| HK1250679A1 (zh) | 2015-04-11 | 2019-01-11 | Helperby Therapeutics Limited | 口腔用组合物 |
| GB201518969D0 (en) | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| CN106924261A (zh) * | 2016-04-12 | 2017-07-07 | 郑海英 | 一种防治牙体牙髓感染的药物组合物 |
| GB201610869D0 (en) | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
| GB201612093D0 (en) | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
| GB201616014D0 (en) | 2016-09-20 | 2016-11-02 | Helperby Therapeutics Ltd | Combination |
| GB201616909D0 (en) | 2016-10-05 | 2016-11-16 | Helperby Therapeutics Ltd | Combination |
| GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
| GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
| GB201709193D0 (en) | 2017-06-09 | 2017-07-26 | Helperby Therapeutics Ltd | Combination |
| CN108558854A (zh) * | 2017-06-10 | 2018-09-21 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
| CN108690012A (zh) * | 2017-06-10 | 2018-10-23 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
| GB201807046D0 (en) | 2018-04-30 | 2018-06-13 | Helperby Therapeutics Ltd | Combination |
| GB201913068D0 (en) | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
| GB201914847D0 (en) | 2019-10-14 | 2019-11-27 | Helperby Therapeutics Ltd | Combination |
| GB202213750D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial |
| GB202213753D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial combinations |
| GB202314387D0 (en) | 2023-09-20 | 2023-11-01 | Helperby Therapeutics Ltd | Antimicrobial combinations |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3324122A (en) | 1964-12-14 | 1967-06-06 | Norwich Pharma Co | Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines |
| US3542784A (en) * | 1968-04-05 | 1970-11-24 | Norwich Pharma Co | 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines |
| DE2140280A1 (de) | 1970-08-12 | 1972-02-17 | Chemische Fabrik von Heyden GmbH, 8000 München | 4 Amino 2 eckige Klammer auf 2 (5 Nitro 2 furyl)vinyl eckige Klammer zu chinazolinderivate, Herstellungsver fahren dafür und Arzneimittel daraus |
| US3974277A (en) * | 1974-09-06 | 1976-08-10 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents |
| US3970648A (en) * | 1974-09-06 | 1976-07-20 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines |
| US3973021A (en) * | 1974-09-06 | 1976-08-03 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide |
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| US6148377A (en) * | 1996-11-22 | 2000-11-14 | Mangosoft Corporation | Shared memory computer networks |
| US5925527A (en) | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
| CA2279977A1 (en) | 1997-02-04 | 1998-08-06 | John S. Kiely | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
| SK113299A3 (en) * | 1997-02-28 | 2001-05-10 | Pfizer Prod Inc | Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| TR199902094T2 (xx) * | 1997-02-28 | 1999-12-21 | Prizer Products Inc. | 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri. |
| US6184377B1 (en) | 1997-12-15 | 2001-02-06 | Sepracor Inc. | Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof |
| US6943159B1 (en) * | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
| US20020025968A1 (en) * | 1998-04-15 | 2002-02-28 | Rifat Pamukcu | Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives |
| US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
| US6667300B2 (en) * | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| GEP20084317B (en) | 2000-04-25 | 2008-02-25 | Icos Corp | Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| US6479499B1 (en) * | 2000-06-28 | 2002-11-12 | National Science Council | 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions |
| UY27224A1 (es) * | 2001-03-23 | 2002-10-31 | Bayer Corp | Inhibidores de la rho-quinasa |
| US7645878B2 (en) * | 2002-03-22 | 2010-01-12 | Bayer Healthcare Llc | Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof |
| MXPA04010539A (es) | 2002-04-26 | 2005-01-25 | Nippon Shinyaku Co Ltd | Derivados de quinazolina y medicamentos que los contienen. |
| WO2004004661A2 (en) | 2002-07-09 | 2004-01-15 | Point Therapeutics, Inc. | Boroproline compound combination therapy |
| EP1660486A4 (en) | 2003-08-08 | 2006-12-13 | Ulysses Pharmaceutical Product | HALOGENATED CHINAZOLINYL NITROFURANES AS ANTIBACTERIAL AGENTS |
-
2004
- 2004-08-06 EP EP04761630A patent/EP1660486A4/en not_active Withdrawn
- 2004-08-06 CN CNA2004800228169A patent/CN1832941A/zh active Pending
- 2004-08-06 AU AU2004262533A patent/AU2004262533A1/en not_active Abandoned
- 2004-08-06 JP JP2006522859A patent/JP2007501809A/ja not_active Withdrawn
- 2004-08-06 CA CA002534405A patent/CA2534405A1/en not_active Abandoned
- 2004-08-06 BR BRPI0413372-2A patent/BRPI0413372A/pt not_active IP Right Cessation
- 2004-08-06 MX MXPA06001552A patent/MXPA06001552A/es not_active Application Discontinuation
- 2004-08-06 US US10/567,660 patent/US7410974B2/en not_active Expired - Fee Related
- 2004-08-06 WO PCT/CA2004/001466 patent/WO2005014585A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007501809A5 (https=) | ||
| JP2004533444A5 (https=) | ||
| JP2017531038A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2002525286A5 (https=) | ||
| JP2002520416A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| JP2008509187A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JP2008533191A5 (https=) | ||
| JP2004537516A5 (https=) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2011505356A5 (https=) | ||
| JP2003522198A5 (https=) | ||
| JP2003503449A5 (https=) | ||
| JP2019527724A5 (https=) | ||
| JP2002525323A5 (https=) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| JP2020505354A5 (https=) | ||
| JP2007500222A5 (https=) | ||
| RU2005121908A (ru) | Производные зн-хиназолин-4-она | |
| JP2004502755A5 (https=) | ||
| JP2010539091A5 (https=) | ||
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| JP2019519563A5 (https=) |